United States · Investor

NeoMed

Last cheque observed Sep 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series CSeries BVentureBiotechnologyHealth CareVenture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 28 on record
Since the last cheque3325days00hrs00min00sec
Median round$46MRounds led0 of 28Sole investor1 roundsExits3 from the portfolioMostly inUnited States, 32%
Pitch NeoMed

NeoMed highlights

  1. 01

    28 rounds on record

  2. 02

    Mostly Series C and Series B: 59% of its rounds

  3. 03

    Sole investor in 1 rounds, median $4.7M

  4. 04

    3 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth CareVenture Capital & Private Equity
Based in
Rootstown, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first28 appearances

  1. 2017

    3 rounds

  2. Sept
    SonendoUS · FinSMEs$50MWith 5 others
  3. May
    AxionicsSeries C · US · FinSMEs$15MWith 3 others
  4. Apr
    ArsanisSeries D · US · FinSMEs$46MWith 6 others
  5. 2015

    4 rounds

  6. Oct
    Sequana MedicalSeries C · CH$9.3MWith 5 others
  7. Aug
    JenaValve TechnologySeries C · DE$27MWith 7 others
  8. Aug
    AvitideSeries C · US$7.6MWith 4 others
  9. Jan
    GenkyotexSeries D · CH$21MWith 5 others
  10. 2014

    5 rounds

  11. Sept
    SonendoSeries D · US$35MWith 3 others
  12. Apr
    Wilson TherapeuticsSeries B · SE$40MWith 3 others
  13. Apr
    JenaValve TechnologySeries C · DE$10MWith 8 others
  14. Feb
    InDex PharmaceuticalsGrowth · SE$20MWith 2 others
  15. Jan
    TopiVertVenture · GB$6.8MWith 3 others
  16. 2013

    4 rounds

  17. Sept
    ArsanisSeries B · AT · biospace.com$20MWith 3 others
  18. Jul
    JenaValve TechnologySeries C · DE · finsmes.com$63MWith 7 others
  19. Jun
    DiagnoplexVenture · CH · finsmes.com$1.4MWith 2 others
  20. Jun
    SonendoSeries C · US · finsmes.com$18MWith 4 others
  21. 2012

    2 rounds

  22. Nov
    EndosenseSeries C · CH · finsmes.com$40MWith 7 others
  23. Jun
    SonendoSeries C · US · pevc.dowjones.com$9.2MWith 2 others
  24. 2011

    2 rounds

  25. Aug
    Vessix VascularSeries B · US · finsmes.com$23MWith 3 others
  26. Mar
    NovaShuntSeries B · CH · prnewswire.com$25MWith 4 others
  27. 2010

    1 round

  28. Oct
    Vessix VascularVenture · US · hedgehogs.net$4.7MSole investor
  29. 2009

    1 round

  30. Oct
    EndosenseSeries B · CH · onbiovc.com$36MWith 6 others
  31. 2008

    2 rounds

  32. Dec
    DiagnoplexSeries A · CH · bio-medicine.org$8.3MWith 1 other
  33. Jun
    CreabilisSeries A · GB$31MWith 1 other
  34. 2007

    2 rounds

  35. Dec
    PregLemSeries B · GB$32MWith 2 others
  36. Jun
    PregLemSeries A · GB$26MWith 2 others
  37. 2005

    2 rounds

  38. Oct
    Kuros BiosurgeryVenture · CH · kuros.ch$4.3MWith 5 others
  39. Jan
    Kuros BiosurgerySeries B · CH · kuros.ch$5.4MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

EndosenseBought by St. Jude Medical$170MAug 2013
Vessix VascularBought by Boston Scientific$300MNov 2012
PregLemBought by Richter GroupUndisclosedOct 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as NeoMed. A count of rooms they were both in, not a relationship either has claimed.

VI PartnersVC firm10rounds togetherOrbiMedPrivate equity8rounds togetherEdmond de Rothschild Venture CapitalGrowth equity5rounds togetherGimvPrivate equity5rounds togetherLegend CapitalVC firm4rounds togetherAtlas VentureVC firm3rounds togetherDEFI Gestion SAInvestment firm3rounds togetherFjord VenturesVC firm3rounds togetherMVM Life Science PartnersVC firm3rounds togetherSV Life SciencesVC firm3rounds togetherSofinnova PartnersVC firm3rounds togetherDeclaration PartnersFamily office2rounds together

Recently backed

The latest companies NeoMed put money into.

Sonendo$50M · Sept 2017Arsanis$46M · Apr 2017

Quick answers about NeoMed

What does NeoMed invest in?

NeoMed invests most often at Series C and Series B (59% of the rounds on record), in sectors such as Biotechnology, Health Care and Venture Capital & Private Equity.

How active is NeoMed?

28 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2017.

What has NeoMed invested in recently?

Its most recent investments on record: Sonendo (Undisclosed round, Sept 2017), Axionics (Series C, May 2017) and Arsanis (Series D, Apr 2017).

How big are NeoMed's cheques?

The median round it joins is $46M.

Does NeoMed lead rounds?

Rarely, if at all: none of its 28 investments on record names it as the lead.

Where does NeoMed invest?

Most of the companies it backs are in the United States (32%), Switzerland (32%) and the United Kingdom (14%).

Is NeoMed investing now?

No investments in the last 12 months; the latest was in Sept 2017.

Who does NeoMed invest alongside?

Most often VI Partners (10 rounds together), OrbiMed (8 rounds together) and Edmond de Rothschild Venture Capital (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it